Solvay Pharma India Ltd.[Amalgamated] - Research Center
532447 DUPHARPH Group (N.A.) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Dec ' 10 | Dec ' 09 | Dec ' 08 | Dec ' 07 | Dec ' 06 | |
|---|---|---|---|---|---|
| Sales | 296.91 | 243.16 | 201.28 | 167.77 | 157.49 |
| Operating profit | 75.37 | 61.63 | 47.38 | 44.16 | 30.64 |
| Interest | 0.01 | - | 0.01 | 0.03 | 0.08 |
| Gross profit | 79.05 | 63.98 | 51.54 | 47.87 | 34.11 |
| EPS (Rs) | 100.69 | 79.26 | 64.96 | 55.68 | 37.09 |
Annual
results in details
| Dec ' 10 | Dec ' 09 | Dec ' 08 | Dec ' 07 | Dec ' 06 | |
|---|---|---|---|---|---|
| Other income | 3.69 | 2.35 | 4.17 | 3.74 | 3.56 |
| Stock adjustment | 0.73 | 2.19 | -5.20 | 0.75 | -3.81 |
| Raw material | 54.47 | 49.79 | 43.53 | 32.91 | 30.96 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 33.74 | 26.48 | 21.38 | 18.82 | 17.31 |
| Excise | - | - | - | - | 13.39 |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 132.61 | 103.07 | 94.19 | 71.13 | 69.00 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.20 | 4.57 | 1.33 | 4.97 | 4.59 |
| Taxation | 24.99 | 20.63 | 17.41 | 14.78 | 10.79 |
| Net profit / loss | 50.85 | 40.03 | 32.80 | 28.12 | 18.73 |
| Extra ordinary item | - | 1.25 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.05 | 5.05 | 5.05 | 5.05 | 5.05 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 5.63 | 15.73 | 15.73 | 15.73 | 15.73 |
| Agg.of non promotoholding (%) | 11.15 | 31.15 | 31.15 | 31.15 | 31.15 |
| OPM (%) | 25.38 | 25.35 | 23.54 | 26.32 | 19.45 |
| GPM (%) | 26.30 | 26.06 | 25.09 | 27.91 | 21.18 |
| NPM (%) | 16.92 | 16.30 | 15.97 | 16.39 | 11.63 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis